编号：2022-007 证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------------------|-----------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | 特定对象调研 | 分析师会议 | | 投资者关 | | □媒体采访 □业绩说 ...

编号：2022-009 证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |---------------------------|------------------------------------|-------------------------------------------------------------------------------------------------------| | | 特定对象调研 | 分析师会议 | | | □媒体采访 | 业绩说明会 | | 投资者关系活 | □新闻发布会 □路演活动 | | | 动类别 | 现场参观 | 其他 2022 年安徽辖区上市公司投资者 | | | 网上集体接待日活动） | | | 参与单位名称 | 线上参与 2022 | 年安徽辖区上市公司投资者网上集体接待日活动的中 | | 及人员姓名 | 小投资者及机构投资者 | | | 时间 | 2022 年 9 月 7 日 | 16:00-17:30 | | 地点 | "全景路演"（ | http:/ ...

证券代码：301108 证券简称：洁雅股份 公告编号：2022-064 铜陵洁雅生物科技股份有限公司 关于参加安徽辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，铜陵洁雅生物科技股份有限公司（以下 简称"公司"）将参加由安徽证监局指导、安徽上市公司协会与深圳市全景网络 有限公司联合举办的"2022 年安徽辖区上市公司投资者集体接待日活动"，现 将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参与 本次互动交流，活动时间为 2022 年 9 月 7 日（周三）16:00-17:30。届时公司高 管将在线就公司 2022 年半年度报告中的公司业绩、公司治理、发展战略、经营 状况、融资计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟 通与交流，欢迎广大投资者踊跃参与！ 特此公告。 铜陵洁雅生物科技股份有限公司董事会 2022 年 9 月 ...

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥359.55 million, a decrease of 42.62% compared to ¥626.57 million in the same period last year[22]. - The net profit attributable to shareholders of the listed company was approximately ¥89.16 million, down 35.01% from ¥137.18 million in the previous year[22]. - Basic earnings per share decreased by 51.11% to ¥1.10, down from ¥2.25 in the previous year[22]. - The weighted average return on net assets was 5.16%, a decline of 21.73% from 26.89% in the previous year[22]. - The gross margin for wet wipes was 28.90%, down 1.88% from the previous year, while the gross margin for facial masks was 52.07%, a decrease of 4.47%[53]. - The company's revenue for the first half of 2022 was CNY 359.55 million, a decrease of 42.62% compared to CNY 626.57 million in the same period last year, primarily due to a significant drop in sales of disinfectant wet wipes[51]. - The cost of sales also decreased by 42.67% to CNY 242.66 million from CNY 423.29 million, reflecting the same decline in product sales[51]. - Research and development expenses were reduced by 43.43% to CNY 13.39 million from CNY 23.66 million, indicating a decrease in investment in new product development[51]. - The company reported a comprehensive income total of CNY 89,155,653.9 for the period, reflecting the overall financial performance despite cash flow challenges[169]. Cash Flow and Assets - The net cash flow from operating activities increased by 36.97% to approximately ¥139.35 million, compared to ¥101.73 million in the same period last year[22]. - Cash and cash equivalents at the end of the reporting period amounted to ¥1,187,452,933.09, representing 57.35% of total assets, a decrease of 11.62% compared to the previous year[57]. - Accounts receivable increased to ¥177,424,329.08, accounting for 8.57% of total assets, up by 0.68% year-on-year[57]. - Inventory decreased to ¥100,747,364.77, making up 4.87% of total assets, down by 2.08% due to a reduction in stock[57]. - Total assets at the end of the reporting period were approximately ¥2.07 billion, an increase of 0.88% from ¥2.05 billion at the end of the previous year[22]. - The total cash inflow from investment activities was CNY 50,685,000.00, compared to CNY 25,612.20 in the previous year, indicating a significant increase in investment returns[167]. - The total cash and cash equivalents at the end of the period were CNY 1,104,537,565.32, down from CNY 1,337,945,001.60 at the beginning of the period, a decrease of approximately 17.5%[168]. Investment and Fundraising - The company reported a net fundraising amount of ¥1,031,831,424.91 after deducting issuance costs from the total fundraising of ¥1,162,721,769.66[66]. - The total amount raised from the initial public offering was approximately RMB 1.16 billion, with a net amount of RMB 1.03 billion after deducting issuance costs[69]. - The company plans to use RMB 1.9 billion of the raised funds to permanently supplement working capital, ensuring the funding needs for investment projects are met[70]. - The company has committed to several investment projects, including a multifunctional wet wipes expansion project with an investment of RMB 26.09 million, which is currently under construction[69]. - The total amount of over-raised funds is RMB 656.08 million, which is being allocated for various projects and working capital[70]. Risks and Challenges - The company faces risks related to technology research and development, particularly in the wet wipes industry, which requires expertise across multiple disciplines[78]. - The company is exposed to raw material price fluctuation risks, as direct materials constitute a significant portion of the main business costs[79]. - The company has a high customer concentration risk, relying heavily on major clients such as Reckitt Group and Procter & Gamble for revenue[80]. - The company is adopting an ODM/OEM model, which poses risks related to brand recognition and market expansion for its own products[82]. - The company is vigilant about changes in import policies of export countries, which could affect its revenue and profit margins[87]. Corporate Governance and Management - The company appointed a new CFO, Yang Fanlong, on April 26, 2022, after the previous CFO, Wang Cuixia, resigned for personal reasons[98]. - The board of directors underwent a significant reshuffle on June 27, 2022, with multiple new appointments including the chairman, Cai Yingchuan, and several independent directors[99]. - The company has a stable management team with over ten years of service, contributing to improved operational efficiency and profitability[48]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[104]. - The company has maintained good integrity status without any overdue debts or unfulfilled commitments[120]. Research and Development - The company focuses on independent research and development, ensuring compliance with legal standards and product performance metrics[40]. - The company has established a comprehensive quality management system based on international standards, which has facilitated partnerships with major global retail brands[44]. - The company has achieved dual certification for its environmental management (ISO 14001:2015) and occupational health and safety management (ISO 45001:2018) systems[106]. - The company aims to enhance its research and development efforts to drive future growth and innovation[172]. Shareholder Information - The company had a total of 81,209,818 shares outstanding, with 100% of shares accounted for[141]. - The largest shareholder, 蔡英传, holds 42,946,052 shares, representing a significant portion of the total shares[143]. - The company plans to maintain its current shareholder structure with no immediate changes anticipated[145]. - The next scheduled release of limited sale shares is set for December 3, 2022, for several shareholders[143].

Financial Performance - The company's revenue for Q1 2022 was ¥180,610,587.09, a decrease of 47.91% compared to ¥346,738,017.92 in the same period last year[4] - Net profit attributable to shareholders was ¥47,447,960.74, down 42.22% from ¥82,116,090.03 year-on-year[4] - Basic and diluted earnings per share decreased by 57.04%, from ¥1.35 to ¥0.58[4] - Operating profit for the quarter was ¥54,834,264.56, representing a decline of 41.6% from ¥93,865,116.01 in the same period last year[19] - Net profit for the first quarter was ¥47,447,960.74, a decrease of 42.3% compared to ¥82,116,090.03 in the previous year[19] - The total comprehensive income attributable to the parent company was CNY 47,447,960.74, consistent with the net profit figure[20] Cash Flow - The net cash flow from operating activities increased significantly by 4,903.47%, reaching ¥134,352,344.73 compared to ¥2,685,185.44 in the previous year[4] - Cash inflow from operating activities totaled CNY 331,014,121.40, an increase of 36.3% from CNY 243,018,624.06 in the previous year[22] - The company reported a significant increase in cash received from sales of goods and services, amounting to CNY 296,695,480.37, up from CNY 215,995,145.34 in the previous year[22] - Cash outflow from investment activities was CNY 258,852,991.50, compared to CNY 40,921,274.40 in the same period last year[23] - The net cash flow from investment activities was -CNY 258,852,991.50, worsening from -CNY 40,921,274.40 in Q1 2021[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,087,763,153.42, reflecting a 1.72% increase from the previous year-end[4] - Total liabilities decreased to ¥346,883,522.17 from ¥359,095,153.92 at the start of the year, reflecting a reduction of 3.2%[18] - Cash and cash equivalents at the end of the quarter were ¥1,288,106,658.71, down 9.0% from ¥1,415,558,250.78 at the beginning of the year[17] - Inventory decreased to ¥117,486,742.90 from ¥142,634,911.84, a decline of 17.6%[17] - The company’s deferred income tax assets rose to ¥4,596,974.55 from ¥3,778,798.66, an increase of 21.6%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,701[10] - The company reported a total of 42,946,052 shares held by the largest shareholder, Cai Yingchuan, representing 52.88% of the total shares[11] - The second largest shareholder, Tongling Mingyuan Venture Capital Management Co., holds 8,360,000 shares, accounting for 10.29%[11] - The company has a total of 61,955,126 restricted shares, with no shares released during the reporting period[14] - The company has a total of 2,164,030 shares held by shareholder Feng Yan, which are also restricted until June 3, 2025[13] - The company has a total of 1,000,000 shares held by shareholder Zhang Qiuping, with restrictions until December 3, 2022[13] - The company has a total of 398,956 shares held by shareholder Xu Yulin, which are restricted until December 3, 2022[13] - The company has a total of 169,120 shares held by shareholder Wang Cuixia, with restrictions until October 25, 2023[14] - The company has a total of 1,047,766 shares issued through offline placement, all of which are restricted until June 3, 2022[14] Research and Development - Research and development expenses decreased by 52.93%, totaling ¥6,045,982.83 compared to ¥12,844,551.71 in the previous year[8] Government Support - The company received government subsidies amounting to ¥2,498,938.51, contributing to the overall financial performance[6] Strategic Developments - The company has not reported any new strategies or market expansions during the quarter[15] - The company has not disclosed any new product developments or technological advancements in the current report[15] Financial Costs - The company reported a financial expense of -¥5,433,757.22, compared to -¥1,577,881.87 in the previous period, indicating a significant increase in financial costs[19]

Financial Performance - The company's operating revenue for 2021 was ¥984,448,664.58, representing a 32.49% increase compared to ¥743,010,527.73 in 2020[21]. - The net profit attributable to shareholders for 2021 was ¥220,048,412.44, a 22.50% increase from ¥179,634,919.88 in 2020[21]. - The net profit after deducting non-recurring gains and losses was ¥210,221,265.88, up 22.26% from ¥171,949,886.51 in 2020[21]. - The company's total assets at the end of 2021 reached ¥2,052,526,824.43, a 139.08% increase from ¥858,495,140.41 at the end of 2020[21]. - The net assets attributable to shareholders increased by 283.52% to ¥1,693,431,670.51 at the end of 2021 from ¥441,551,833.16 at the end of 2020[21]. - The basic earnings per share for 2021 was ¥3.52, reflecting a 19.32% increase from ¥2.95 in 2020[21]. - The weighted average return on equity decreased to 34.51% in 2021 from 50.96% in 2020, a decline of 16.45%[21]. - The company reported a net cash flow from operating activities of ¥200,176,869.72, which is a 6.73% increase from ¥187,561,277.53 in 2020[21]. - In 2021, the company achieved a revenue of CNY 984.45 million, representing a year-on-year growth of 32.49%[75]. - The net profit for 2021 was CNY 220.05 million, with a year-on-year increase of 22.50%[75]. - The total sales revenue of wet wipes in China was approximately 22.64 billion yuan in 2020, with the top 10 manufacturers accounting for about 36.8% of the total sales, an increase from 30.2% in 2019[48]. Dividend Distribution - The company plans to distribute a cash dividend of 7.50 RMB per 10 shares to all shareholders, based on a total of 81,209,818 shares[4]. - The company implemented a cash dividend policy, distributing 7.50 CNY per 10 shares, totaling 60,907,363.50 CNY (including tax), which represents 100% of the total profit distribution[190][192]. - The company did not distribute cash dividends for the 2020 fiscal year, opting instead to retain profits for future development[189]. Market and Industry Insights - The global retail market size for wet wipes reached $16.08 billion in 2020, with a projected compound annual growth rate of over 6% from 2020 to 2025[32]. - The Chinese wet wipes market size was $1.6 billion in 2020, making it the largest personal care wet wipes market in the Asia-Pacific region[36]. - The company operates in a highly regulated industry overseen by the National Health Commission, the State Administration for Market Regulation, and the National Medical Products Administration[38]. - The market for wet wipes is characterized by a high degree of marketization with many small-scale manufacturers, while foreign brands dominate the market[47]. - The company ranks 3rd, 5th, 5th, and 6th among national manufacturers and brands of wet wipes from 2017 to 2020 based on sales revenue[48]. Product Development and Innovation - The company has over 60 varieties of wet wipes across six major series, including baby, adult functional, antibacterial, household cleaning, medical care, and pet cleaning[51]. - The company is focusing on product segmentation, targeting specific demographics such as male or female consumers to enhance brand appeal[43]. - There is a growing trend towards "less is more" in baby wipes, with the company developing "zero preservative" and "pure water" formula series[45]. - The company is actively participating in the development and revision of industry standards to align with market feedback and product development[41]. - The company has completed 9 R&D projects and launched over 20 new products during the reporting period, enhancing customer retention[77]. - The company has established a complete quality management system based on international standards, ensuring product quality through multiple certifications[68]. - The company is focusing on developing new products such as preservative-free facial masks and eco-friendly baby wipes to meet market demands[100]. Research and Development - Research and development expenses rose by 32.97% year-on-year to 36,382,036.30 yuan, driven by increased investment in R&D[95]. - The company has a specialized R&D team for cosmetics and facial masks, leveraging years of experience with renowned clients[66]. - The company is increasing R&D investment to enhance product offerings and reduce reliance on ODM/OEM models, aiming to develop its own brand products[134]. - The company has established a scientific human resource management system to optimize personnel recruitment, selection, training, compensation management, and performance evaluation[197]. Corporate Governance and Management - The company emphasizes the importance of accurate financial reporting, with the responsible parties confirming the authenticity and completeness of the annual report[3]. - The company has a stable core technical team, all of whom are current employees, contributing to its R&D capabilities in wet wipes and facial masks[66]. - The governance structure includes a board of directors, supervisory board, and management team, ensuring effective decision-making and oversight[194]. - The company has maintained a transparent information disclosure process, ensuring all shareholders have equal access to information[148]. - The company has established a comprehensive internal control management system to ensure compliance with regulations[145]. Financial Management and Cash Flow - The company's operating cash inflow increased by 51.98% to ¥1,110,138,895.68, driven by a 50.85% rise in sales cash recovery and a 58.04% increase in tax refunds received[103]. - Operating cash outflow rose by 67.62% to ¥909,962,025.96, primarily due to a 69.04% increase in cash paid for goods and services and a 78.01% rise in cash paid to employees[104]. - The total cash and cash equivalents increased by 824.37% to ¥1,106,347,065.34, reflecting the overall positive cash flow situation[105]. - The company plans to establish a special account for raised funds, ensuring proper management and oversight of financial resources[179]. Risk Management - The company has outlined potential risks and corresponding mitigation strategies in the section discussing future development prospects[4]. - The company faces risks related to high customer concentration, as it primarily serves well-known global brands, which could impact revenue if these clients change procurement strategies[132]. - The company is implementing measures to mitigate risks from raw material price volatility by strengthening strategic partnerships with suppliers and improving procurement strategies[131]. - The company acknowledges the risk of unsustainable rapid growth, particularly in the context of potential declines in demand for antibacterial products as the pandemic situation evolves[142]. Sustainability and Corporate Social Responsibility - The company is dedicated to sustainability and innovation, aligning its strategies with industry trends and consumer demands[164]. - The company is leveraging natural fiber technology to create fully biodegradable wet wipes, aligning with environmental sustainability trends[99]. - The company actively engages with stakeholders to balance interests and fulfill corporate social responsibilities[147]. Employee Management and Compensation - The total remuneration for directors, supervisors, and senior management in 2021 amounted to 4.8529 million yuan[172]. - The company emphasizes employee training and development, focusing on skills and technical talent to align with strategic growth[187]. - The company has established a competitive and fair compensation system, combining position-based pay with performance incentives[186]. - The company has no current stock incentive plans or employee stock ownership plans in place[193].